Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K31/401—Proline; Derivatives thereof, e.g. captopril
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
  • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
  • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2121/00—Preparations for use in therapy

Landscapes

• Health & Medical Sciences (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Epidemiology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=47913395

Family Applications (1)

Country Status (21)

Families Citing this family (10)

Family Cites Families (5)

• 2013
  • 2013-02-05 US US13/759,647 patent/US20130245089A1/en not_active Abandoned
  • 2013-03-15 EP EP13711004.5A patent/EP2827858B1/en active Active
  • 2013-03-15 KR KR1020217003250A patent/KR102438597B1/ko active Active
  • 2013-03-15 RU RU2014141365A patent/RU2638795C2/ru active
  • 2013-03-15 WO PCT/EP2013/055324 patent/WO2013139687A1/en not_active Ceased
  • 2013-03-15 CA CA2859940A patent/CA2859940C/en active Active
  • 2013-03-15 CN CN201380015189.5A patent/CN104203232A/zh active Pending
  • 2013-03-15 DK DK13711004.5T patent/DK2827858T3/en active
  • 2013-03-15 RS RS20160860A patent/RS55250B1/sr unknown
  • 2013-03-15 PT PT137110045T patent/PT2827858T/pt unknown
  • 2013-03-15 MX MX2014010586A patent/MX356948B/es active IP Right Grant
  • 2013-03-15 PL PL13711004T patent/PL2827858T3/pl unknown
  • 2013-03-15 KR KR1020147026019A patent/KR20140133583A/ko not_active Ceased
  • 2013-03-15 HR HRP20161295TT patent/HRP20161295T1/hr unknown
  • 2013-03-15 JP JP2015500851A patent/JP6224690B2/ja active Active
  • 2013-03-15 ES ES13711004.5T patent/ES2593066T3/es active Active
  • 2013-03-15 LT LTEP13711004.5T patent/LT2827858T/lt unknown
  • 2013-03-15 HK HK15105538.1A patent/HK1204934A1/xx unknown
  • 2013-03-15 KR KR1020197008801A patent/KR20190035957A/ko not_active Ceased
  • 2013-03-15 KR KR1020167019798A patent/KR20160089549A/ko not_active Ceased
  • 2013-03-15 BR BR112014018135A patent/BR112014018135A8/pt not_active Application Discontinuation
  • 2013-03-15 SI SI201330310A patent/SI2827858T1/sl unknown
  • 2013-03-15 CN CN201910030832.0A patent/CN110013478A/zh active Pending
  • 2013-03-15 HU HUE13711004A patent/HUE029933T2/en unknown
• 2015
  • 2015-01-14 US US14/596,747 patent/US20150126575A1/en not_active Abandoned
• 2016
  • 2016-10-05 CY CY20161100996T patent/CY1118070T1/el unknown
  • 2016-10-06 JP JP2016197838A patent/JP2017061461A/ja active Pending
• 2019
  • 2019-07-12 US US16/510,256 patent/US20190328708A1/en not_active Abandoned
• 2020
  • 2020-11-18 US US16/951,153 patent/US11738003B2/en active Active

Also Published As

Similar Documents